Squarepoint Ops LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q2 2020$265,000
-24.7%
4,328
-30.4%
0.00%
-55.6%
Q1 2020$352,000
-76.6%
6,219
-76.5%
0.01%0.0%
Q4 2019$1,506,000
+54.5%
26,442
+45.1%
0.01%0.0%
Q3 2019$975,000
-4.7%
18,222
+6.4%
0.01%
-10.0%
Q2 2019$1,023,000
+112.7%
17,133
+122.1%
0.01%
+100.0%
Q1 2019$481,000
-0.2%
7,714
-3.0%
0.01%
-16.7%
Q4 2018$482,000
+6.2%
7,950
+2.5%
0.01%
+20.0%
Q3 2018$454,0007,7580.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders